Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
Clinical trial NCT03973047 · COMPLETED
Trial details
- NCT number
- NCT03973047
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2019-07-19
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.